Basile Njei

Datos Biográficos

ID5543464
NOMBREBasile Njei
NOMBRESBasile
APELLIDONjei
FIRMANJEI B
AFILIACIONESYale University
ORCID0000-0003-0714-4368
VERIFICADOSí
TOTAL DE OBRAS6
TOTAL DE CITAS0
TOTAL COMO AUTOR6
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2019
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0

  • The precarious state of community engagement in African clinical trials

    Open AccessLuchuo Engelbert Bain, Sidney Sangong et al.ARTICLEPLOS Global Public Health2026

    Community engagement (CE) is an ethical imperative for clinical trials, yet it is often treated as a peripheral activity rather than a core scientific requirement. In light of the Africa CDC’s mandate to achieve 60% local vaccine production by 2040, establishing robust community engagement frameworks within African clinical trials is vital. We systematically synthesized evidence on CE approaches, with a focus on funding and sustainability, utiliz…

  • A conceptual framework for measuring AI health equity

    Open AccessBasile Njei, Ulrick Sidney Kanmounye et al.ARTICLEInternational Journal for Equity…2026

    BACKGROUND: Artificial intelligence (AI) is increasingly embedded in health systems globally and has the potential to improve efficiency, diagnostic accuracy, and decision support. However, its benefits remain unevenly distributed, particularly in low- and middle-income countries (LMICs). Models developed using datasets from specific populations may perform poorly in other settings, reinforcing structural inequities rather than correcting them. O…

  • Visa restrictions

    Open AccessLuchuo Engelbert Bain, Samuel Akombeng Ojong et al.ARTICLEPLOS Global Public Health2026

  • Socioeconomic and demographic disparities in the impact of digestive diseases in the middle East and North Africa (Mena) region

    Open AccessOmar Al Ta’ani, Yazan A Al-Ajlouni et al.ARTICLEInternational Journal for Equity…2025

    Despite a reduction in mortality and DALY rates, the persistently high incidence rates of DD in the MENA region underscores ongoing public health challenges. Socioeconomic factors strongly influence disease burden, highlighting the need for targeted interventions to address disparities and improve digestive disease outcomes across the region

  • The burden of cirrhosis and other chronic liver disease in the middle east and North Africa (Mena) region over three decades

    Open AccessOmar Al Ta’ani, Wesam Aleyadeh et al.ARTICLEBMC Public Health2024

    The study highlights evolving trends in cirrhosis and other chronic liver disease within the MENA region, emphasizing the necessity for comprehensive, etiology, and gender-specific interventions. Despite an increasing incidence, the observed improvements in mortality rates and age-standardized disability burden indicate progress in public health efforts to mitigate cirrhosis's impact. These findings point to the complex nature of cirrhosis outcom…

  • Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus

    Basile Njei, Denise Esserman et al.ARTICLEMedical Care2019Referencias: 27

    BACKGROUND: Veterans with hepatitis C virus (HCV) infection may face geographic obstacles to obtaining treatment. OBJECTIVE: We studied the influence of region and rural versus urban residence on receipt of direct-acting antiretroviral (DAA) medications for HCV. SUBJECTS: Veterans receiving care within Veterans Affairs Healthcare System born between 1945 and 1965. RESEARCH DESIGN: This is a observational study using national electronic health rec…